The Enterprise Value as of November 2024 (TTM) for Edgewise Therapeutics, Inc. (EWTX) is 3.01B

According to Edgewise Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 3.01B. This represents a change of 87.50% compared to the average of 1.60B of the last 4 quarters.

Edgewise Therapeutics, Inc. (EWTX) Historical Enterprise Value (quarterly & annually)

How has EWTX Enterprise Value performed in the past?

The mean historical Enterprise Value of Edgewise Therapeutics, Inc. over the last ten years is 849.71M. The current 3.01B Enterprise Value has changed 35.31% with respect to the historical average. Over the past ten years (40 quarters), EWTX's Enterprise Value was at its highest in in the September 2024 quarter at 2.46B. The Enterprise Value was at its lowest in in the March 2021 quarter at -170340290.00.

Edgewise Therapeutics, Inc. (EWTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Edgewise Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Edgewise Therapeutics, Inc. (EWTX) Average Enterprise Value

How has EWTX Enterprise Value performed in the past?

The current Enterprise Value of Edgewise Therapeutics, Inc. (EWTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Edgewise Therapeutics, Inc. (EWTX) Enterprise Value vs. Peers

How is EWTX’s Enterprise Value compared to its peers?

Edgewise Therapeutics, Inc.’s Enterprise Value is greater than Century Therapeutics, Inc. (104.89M), greater than C4 Therapeutics, Inc. (307.45M), greater than Mineralys Therapeutics, Inc. (523.81M), greater than Cullinan Oncology, Inc. (630.54M), greater than Talaris Therapeutics, Inc. (50.00M), greater than Adicet Bio, Inc. (-13122100.00), greater than Vor Biopharma Inc. (34.31M), greater than Ikena Oncology, Inc. (45.73M), greater than Design Therapeutics, Inc. (290.40M), greater than Xilio Therapeutics, Inc. (-13633399.00), greater than Eliem Therapeutics, Inc. (119.64M), greater than Werewolf Therapeutics, Inc. (-1378920.00), greater than Decibel Therapeutics, Inc. (102.82M), greater than Celcuity Inc. (574.33M), greater than TCR2 Therapeutics Inc. (79.12M), less than Revolution Medicines, Inc. (9.43B), greater than Black Diamond Therapeutics, Inc. (139.97M), greater than Atreca, Inc. (-8620212.00), greater than Passage Bio, Inc. (24.72M),

Build a custom stock screener for Edgewise Therapeutics, Inc. (EWTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Edgewise Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Edgewise Therapeutics, Inc. (EWTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Edgewise Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.